Planned Parenthood Sees 760% Increase in IUD Appointments Post-Election

Following Donald Trump’s re-election, online retailers and providers of emergency contraceptives saw a dramatic rise in sales, driven by concerns over reproductive healthcare restrictions.

Winx Health, previously known as Stix, reported an extraordinary 966% sales spike for its morning-after pill, Restart, within 60 hours of the election.

Similarly, Wisp, a telehealth company specializing in sexual and reproductive health, noted a 1000% surge in sales for emergency contraception from November 5-6, particularly in states with abortion restrictions like Texas, Alabama, and Indiana, according to CEO Monica Cepak. She noted that this response mirrored the surge in demand seen when Roe v. Wade was overturned.

There was also a significant increase in demand for long-term birth control options. Planned Parenthood recorded a 760% rise in appointments for intrauterine devices IUDs and a 350% increase for birth control implants on November 6. Vasectomy appointments also spiked by 1200%.

Danika Severino Wynn, vice president of care and access for Planned Parenthood Federation of America, attributed this rush to people’s concerns about potential restrictions on reproductive rights.

This trend is reminiscent of the increase in long-acting reversible contraceptives after Trump’s 2016 victory, as reported in a JAMA Internal Medicine study.

Trump’s first term included restrictions on contraceptive funding, sparking fears of further limitations.

Although his stance on contraception has been inconsistent—initially suggesting openness to restrictions before later denying such intentions—uncertainty about future policies has led many to proactively seek birth control options.

Dr. Elise Berlan of Nationwide Children’s Hospital advises individuals concerned about these potential restrictions to consult a healthcare provider to explore options that best meet their needs.

Leave a Comment